LivaNova plc (LIVN) Tops Q4 EPS by 1c, Revenues Miss; Offers FY20 EPS Mid-Point Guidance Below Consensus

Go back to LivaNova plc (LIVN) Tops Q4 EPS by 1c, Revenues Miss; Offers FY20 EPS Mid-Point Guidance Below Consensus

LivaNova (LIVN) Receives FDA Clearance for 3T Heater-Cooler Device Modification

February 25, 2020 2:01 PM EST

LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for a device modification to its 3T Heater-Cooler® devices. The modification includes the installation of a 3T Aerosol Collection Set, as well as testing that demonstrates the effectiveness of its operating instructions. This modification has been implemented at no cost to customers on devices that have already been... More